 | • レポートコード：QAF27565 • 出版社/出版日：QYResearch / 2021年4月9日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の抗凝固剤市場について種類別（抗血小板凝集阻害剤（PAI）、低分子量ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、直接第Xa因子阻害剤（DFXa）、ビタミンK拮抗薬（VKA）、その他）、用途別（VTE、ACS/MI、AF、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗凝固剤市場の概要 ・世界の主要地域別抗凝固剤市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の抗凝固剤市場規模2016-2021：種類別（抗血小板凝集阻害剤（PAI）、低分子量ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、直接第Xa因子阻害剤（DFXa）、ビタミンK拮抗薬（VKA）、その他） ・世界の抗凝固剤市場予測2012-2027：種類別（抗血小板凝集阻害剤（PAI）、低分子量ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、直接第Xa因子阻害剤（DFXa）、ビタミンK拮抗薬（VKA）、その他） ・世界の抗凝固剤市場規模2016-2021：用途別（VTE、ACS/MI、AF、その他） ・世界の抗凝固剤市場予測2012-2027：用途別（VTE、ACS/MI、AF、その他） ・抗凝固剤のアメリカ市場規模と予測2016-2021 ・抗凝固剤のヨーロッパ市場規模と予測2016-2021 ・抗凝固剤の中国市場規模と予測2016-2021 ・抗凝固剤の日本市場規模と予測2016-2021 ・抗凝固剤の東南アジア市場規模と予測2016-2021 ・抗凝固剤のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi、Bayer、Boehringer Ingelheim、Johnson & Johnson、Genentech (Roche)、AstraZeneca、Bristol-Myers Squibb、Aspen、Lilly、Otsuka、Pfizer、Daiichi Sankyo、The Medicines Company） ・抗凝固剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗凝固剤の市場動向・機会・課題 ・調査の結論 |
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Market Analysis and Insights: Global Anticoagulants Market
The global Anticoagulants market was valued at US$ 1058.4 in 2020 and will reach US$ 1775.1 million by the end of 2027, growing at a CAGR of 9.0% during 2022-2027.
Global Anticoagulants Scope and Market Size
The global Anticoagulants market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anticoagulants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Platelet Aggregation Inhibitors (PAI)
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Direct Factor Xa Inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
Segment by Application
VTE
ACS/MI
AF
Others
The Anticoagulants market is analysed and market size information is provided by regions (countries). Segment by Application, the Anticoagulants market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Sanofi
Bayer
Boehringer Ingelheim
Johnson & Johnson
Genentech (Roche)
AstraZeneca
Bristol-Myers Squibb
Aspen
Lilly
Otsuka
Pfizer
Daiichi Sankyo
The Medicines Company
1 Anticoagulants Market Overview
1.1 Anticoagulants Product Scope
1.2 Anticoagulants Segment by Type
1.2.1 Global Anticoagulants Sales by Type (2016 & 2021 & 2027)
1.2.2 Platelet Aggregation Inhibitors (PAI)
1.2.3 Low-Molecular-Weight Heparin (LMWH)
1.2.4 Direct Thrombin Inhibitor (DTI)
1.2.5 Direct Factor Xa Inhibitors (DFXa)
1.2.6 Vitamin K antagonists (VKA)
1.2.7 Others
1.3 Anticoagulants Segment by Application
1.3.1 Global Anticoagulants Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Anticoagulants Market Estimates and Forecasts (2016-2027)
1.4.1 Global Anticoagulants Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Anticoagulants Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Anticoagulants Price Trends (2016-2027)
2 Anticoagulants Estimates and Forecasts by Region
2.1 Global Anticoagulants Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Anticoagulants Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Anticoagulants Sales Market Share by Region (2016-2021)
2.2.2 Global Anticoagulants Revenue Market Share by Region (2016-2021)
2.3 Global Anticoagulants Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Anticoagulants Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Anticoagulants Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Anticoagulants Estimates and Projections (2016-2027)
2.4.2 Europe Anticoagulants Estimates and Projections (2016-2027)
2.4.3 China Anticoagulants Estimates and Projections (2016-2027)
2.4.4 Japan Anticoagulants Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Anticoagulants Estimates and Projections (2016-2027)
2.4.6 India Anticoagulants Estimates and Projections (2016-2027)
3 Global Anticoagulants Competition Landscape by Players
3.1 Global Top Anticoagulants Players by Sales (2016-2021)
3.2 Global Top Anticoagulants Players by Revenue (2016-2021)
3.3 Global Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulants as of 2020)
3.4 Global Anticoagulants Average Price by Company (2016-2021)
3.5 Manufacturers Anticoagulants Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Anticoagulants Market Size by Type
4.1 Global Anticoagulants Historic Market Review by Type (2016-2021)
4.1.1 Global Anticoagulants Sales Market Share by Type (2016-2021)
4.1.2 Global Anticoagulants Revenue Market Share by Type (2016-2021)
4.1.3 Global Anticoagulants Price by Type (2016-2021)
4.2 Global Anticoagulants Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Anticoagulants Sales Forecast by Type (2022-2027)
4.2.2 Global Anticoagulants Revenue Forecast by Type (2022-2027)
4.2.3 Global Anticoagulants Price Forecast by Type (2022-2027)
5 Global Anticoagulants Market Size by Application
5.1 Global Anticoagulants Historic Market Review by Application (2016-2021)
5.1.1 Global Anticoagulants Sales Market Share by Application (2016-2021)
5.1.2 Global Anticoagulants Revenue Market Share by Application (2016-2021)
5.1.3 Global Anticoagulants Price by Application (2016-2021)
5.2 Global Anticoagulants Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Anticoagulants Sales Forecast by Application (2022-2027)
5.2.2 Global Anticoagulants Revenue Forecast by Application (2022-2027)
5.2.3 Global Anticoagulants Price Forecast by Application (2022-2027)
6 North America Anticoagulants Market Facts & Figures
6.1 North America Anticoagulants Sales by Company
6.1.1 North America Anticoagulants Sales by Company (2016-2021)
6.1.2 North America Anticoagulants Revenue by Company (2016-2021)
6.2 North America Anticoagulants Sales Breakdown by Type
6.2.1 North America Anticoagulants Sales Breakdown by Type (2016-2021)
6.2.2 North America Anticoagulants Sales Breakdown by Type (2022-2027)
6.3 North America Anticoagulants Sales Breakdown by Application
6.3.1 North America Anticoagulants Sales Breakdown by Application (2016-2021)
6.3.2 North America Anticoagulants Sales Breakdown by Application (2022-2027)
7 Europe Anticoagulants Market Facts & Figures
7.1 Europe Anticoagulants Sales by Company
7.1.1 Europe Anticoagulants Sales by Company (2016-2021)
7.1.2 Europe Anticoagulants Revenue by Company (2016-2021)
7.2 Europe Anticoagulants Sales Breakdown by Type
7.2.1 Europe Anticoagulants Sales Breakdown by Type (2016-2021)
7.2.2 Europe Anticoagulants Sales Breakdown by Type (2022-2027)
7.3 Europe Anticoagulants Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)
8 China Anticoagulants Market Facts & Figures
8.1 China Anticoagulants Sales by Company
8.1.1 China Anticoagulants Sales by Company (2016-2021)
8.1.2 China Anticoagulants Revenue by Company (2016-2021)
8.2 China Anticoagulants Sales Breakdown by Type
8.2.1 China Anticoagulants Sales Breakdown by Type (2016-2021)
8.2.2 China Anticoagulants Sales Breakdown by Type (2022-2027)
8.3 China Anticoagulants Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)
9 Japan Anticoagulants Market Facts & Figures
9.1 Japan Anticoagulants Sales by Company
9.1.1 Japan Anticoagulants Sales by Company (2016-2021)
9.1.2 Japan Anticoagulants Revenue by Company (2016-2021)
9.2 Japan Anticoagulants Sales Breakdown by Type
9.2.1 Japan Anticoagulants Sales Breakdown by Type (2016-2021)
9.2.2 Japan Anticoagulants Sales Breakdown by Type (2022-2027)
9.3 Japan Anticoagulants Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Anticoagulants Market Facts & Figures
10.1 Southeast Asia Anticoagulants Sales by Company
10.1.1 Southeast Asia Anticoagulants Sales by Company (2016-2021)
10.1.2 Southeast Asia Anticoagulants Revenue by Company (2016-2021)
10.2 Southeast Asia Anticoagulants Sales Breakdown by Type
10.2.1 Southeast Asia Anticoagulants Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Anticoagulants Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Anticoagulants Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Anticoagulants Market Facts & Figures
11.1 India Anticoagulants Sales by Company
11.1.1 India Anticoagulants Sales by Company (2016-2021)
11.1.2 India Anticoagulants Revenue by Company (2016-2021)
11.2 India Anticoagulants Sales Breakdown by Type
11.2.1 India Anticoagulants Sales Breakdown by Type (2016-2021)
11.2.2 India Anticoagulants Sales Breakdown by Type (2022-2027)
11.3 India Anticoagulants Sales Breakdown by Application
11.3.1 India Anticoagulants Sales Breakdown by Application (2016-2021)
11.3.2 India Anticoagulants Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Anticoagulants Business
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Anticoagulants Products Offered
12.1.5 Sanofi Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Anticoagulants Products Offered
12.2.5 Bayer Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Business Overview
12.3.3 Boehringer Ingelheim Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Anticoagulants Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Business Overview
12.4.3 Johnson & Johnson Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson & Johnson Anticoagulants Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Genentech (Roche)
12.5.1 Genentech (Roche) Corporation Information
12.5.2 Genentech (Roche) Business Overview
12.5.3 Genentech (Roche) Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Genentech (Roche) Anticoagulants Products Offered
12.5.5 Genentech (Roche) Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Corporation Information
12.6.2 AstraZeneca Business Overview
12.6.3 AstraZeneca Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.6.4 AstraZeneca Anticoagulants Products Offered
12.6.5 AstraZeneca Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Corporation Information
12.7.2 Bristol-Myers Squibb Business Overview
12.7.3 Bristol-Myers Squibb Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bristol-Myers Squibb Anticoagulants Products Offered
12.7.5 Bristol-Myers Squibb Recent Development
12.8 Aspen
12.8.1 Aspen Corporation Information
12.8.2 Aspen Business Overview
12.8.3 Aspen Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Aspen Anticoagulants Products Offered
12.8.5 Aspen Recent Development
12.9 Lilly
12.9.1 Lilly Corporation Information
12.9.2 Lilly Business Overview
12.9.3 Lilly Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Lilly Anticoagulants Products Offered
12.9.5 Lilly Recent Development
12.10 Otsuka
12.10.1 Otsuka Corporation Information
12.10.2 Otsuka Business Overview
12.10.3 Otsuka Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Otsuka Anticoagulants Products Offered
12.10.5 Otsuka Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Business Overview
12.11.3 Pfizer Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Anticoagulants Products Offered
12.11.5 Pfizer Recent Development
12.12 Daiichi Sankyo
12.12.1 Daiichi Sankyo Corporation Information
12.12.2 Daiichi Sankyo Business Overview
12.12.3 Daiichi Sankyo Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Daiichi Sankyo Anticoagulants Products Offered
12.12.5 Daiichi Sankyo Recent Development
12.13 The Medicines Company
12.13.1 The Medicines Company Corporation Information
12.13.2 The Medicines Company Business Overview
12.13.3 The Medicines Company Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.13.4 The Medicines Company Anticoagulants Products Offered
12.13.5 The Medicines Company Recent Development
13 Anticoagulants Manufacturing Cost Analysis
13.1 Anticoagulants Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anticoagulants
13.4 Anticoagulants Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anticoagulants Distributors List
14.3 Anticoagulants Customers
15 Market Dynamics
15.1 Anticoagulants Market Trends
15.2 Anticoagulants Drivers
15.3 Anticoagulants Market Challenges
15.4 Anticoagulants Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anticoagulants Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Anticoagulants Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Anticoagulants Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Anticoagulants Sales (K MT) by Region (2016-2021)
Table 5. Global Anticoagulants Sales Market Share by Region (2016-2021)
Table 6. Global Anticoagulants Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Anticoagulants Revenue Share by Region (2016-2021)
Table 8. Global Anticoagulants Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Anticoagulants Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Anticoagulants Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Anticoagulants Revenue Share Forecast by Region (2022-2027)
Table 12. Global Anticoagulants Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Anticoagulants Sales Share by Company (2016-2021)
Table 14. Global Anticoagulants Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Anticoagulants Revenue Share by Company (2016-2021)
Table 16. Global Anticoagulants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulants as of 2020)
Table 17. Global Anticoagulants Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Anticoagulants Manufacturing Sites and Area Served
Table 19. Manufacturers Anticoagulants Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Anticoagulants Sales (K MT) by Type (2016-2021)
Table 22. Global Anticoagulants Sales Share by Type (2016-2021)
Table 23. Global Anticoagulants Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Anticoagulants Price (USD/MT) by Type (2016-2021)
Table 25. Global Anticoagulants Sales Share by Type (2022-2027)
Table 26. Global Anticoagulants Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Anticoagulants Revenue Share by Type (2022-2027)
Table 28. Global Anticoagulants Price (USD/MT) by Type (2022-2027)
Table 29. Global Anticoagulants Sales (K MT) by Application (2016-2021)
Table 30. Global Anticoagulants Sales Share by Application (2016-2021)
Table 31. Global Anticoagulants Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Anticoagulants Price (USD/MT) by Application (2016-2021)
Table 33. Global Anticoagulants Sales (K MT) by Application (2022-2027)
Table 34. Global Anticoagulants Sales Share by Application (2022-2027)
Table 35. Global Anticoagulants Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Anticoagulants Revenue Share by Application (2022-2027)
Table 37. Global Anticoagulants Price (USD/MT) by Application (2022-2027)
Table 38. North America Anticoagulants Sales (K MT) by Company (2016-2021)
Table 39. North America Anticoagulants Sales Market Share by Company (2016-2021)
Table 40. North America Anticoagulants Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Anticoagulants Revenue Market Share by Company (2016-2021)
Table 42. North America Anticoagulants Sales by Type (2016-2021) & (K MT)
Table 43. North America Anticoagulants Sales Market Share by Type (2016-2021)
Table 44. North America Anticoagulants Sales by Type (2022-2027) & (K MT)
Table 45. North America Anticoagulants Sales Market Share by Type (2022-2027)
Table 46. North America Anticoagulants Sales by Application (2016-2021) & (K MT)
Table 47. North America Anticoagulants Sales Market Share by Application (2016-2021)
Table 48. North America Anticoagulants Sales by Application (2022-2027) & (K MT)
Table 49. North America Anticoagulants Sales Market Share by Application (2022-2027)
Table 50. Europe Anticoagulants Sales (K MT) by Company (2016-2021)
Table 51. Europe Anticoagulants Sales Market Share by Company (2016-2021)
Table 52. Europe Anticoagulants Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Anticoagulants Revenue Market Share by Company (2016-2021)
Table 54. Europe Anticoagulants Sales by Type (2016-2021) & (K MT)
Table 55. Europe Anticoagulants Sales Market Share by Type (2016-2021)
Table 56. Europe Anticoagulants Sales by Type (2022-2027) & (K MT)
Table 57. Europe Anticoagulants Sales Market Share by Type (2022-2027)
Table 58. Europe Anticoagulants Sales by Application (2016-2021) & (K MT)
Table 59. Europe Anticoagulants Sales Market Share by Application (2016-2021)
Table 60. Europe Anticoagulants Sales by Application (2022-2027) & (K MT)
Table 61. Europe Anticoagulants Sales Market Share by Application (2022-2027)
Table 62. China Anticoagulants Sales (K MT) by Company (2016-2021)
Table 63. China Anticoagulants Sales Market Share by Company (2016-2021)
Table 64. China Anticoagulants Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Anticoagulants Revenue Market Share by Company (2016-2021)
Table 66. China Anticoagulants Sales by Type (2016-2021) & (K MT)
Table 67. China Anticoagulants Sales Market Share by Type (2016-2021)
Table 68. China Anticoagulants Sales by Type (2022-2027) & (K MT)
Table 69. China Anticoagulants Sales Market Share by Type (2022-2027)
Table 70. China Anticoagulants Sales by Application (2016-2021) & (K MT)
Table 71. China Anticoagulants Sales Market Share by Application (2016-2021)
Table 72. China Anticoagulants Sales by Application (2022-2027) & (K MT)
Table 73. China Anticoagulants Sales Market Share by Application (2022-2027)
Table 74. Japan Anticoagulants Sales (K MT) by Company (2016-2021)
Table 75. Japan Anticoagulants Sales Market Share by Company (2016-2021)
Table 76. Japan Anticoagulants Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Anticoagulants Revenue Market Share by Company (2016-2021)
Table 78. Japan Anticoagulants Sales by Type (2016-2021) & (K MT)
Table 79. Japan Anticoagulants Sales Market Share by Type (2016-2021)
Table 80. Japan Anticoagulants Sales by Type (2022-2027) & (K MT)
Table 81. Japan Anticoagulants Sales Market Share by Type (2022-2027)
Table 82. Japan Anticoagulants Sales by Application (2016-2021) & (K MT)
Table 83. Japan Anticoagulants Sales Market Share by Application (2016-2021)
Table 84. Japan Anticoagulants Sales by Application (2022-2027) & (K MT)
Table 85. Japan Anticoagulants Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Anticoagulants Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Anticoagulants Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Anticoagulants Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Anticoagulants Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Anticoagulants Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Anticoagulants Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Anticoagulants Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Anticoagulants Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Anticoagulants Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Anticoagulants Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Anticoagulants Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Anticoagulants Sales Market Share by Application (2022-2027)
Table 98. India Anticoagulants Sales (K MT) by Company (2016-2021)
Table 99. India Anticoagulants Sales Market Share by Company (2016-2021)
Table 100. India Anticoagulants Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Anticoagulants Revenue Market Share by Company (2016-2021)
Table 102. India Anticoagulants Sales by Type (2016-2021) & (K MT)
Table 103. India Anticoagulants Sales Market Share by Type (2016-2021)
Table 104. India Anticoagulants Sales by Type (2022-2027) & (K MT)
Table 105. India Anticoagulants Sales Market Share by Type (2022-2027)
Table 106. India Anticoagulants Sales by Application (2016-2021) & (K MT)
Table 107. India Anticoagulants Sales Market Share by Application (2016-2021)
Table 108. India Anticoagulants Sales by Application (2022-2027) & (K MT)
Table 109. India Anticoagulants Sales Market Share by Application (2022-2027)
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Sanofi Anticoagulants Product
Table 114. Sanofi Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Bayer Anticoagulants Product
Table 119. Bayer Recent Development
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Boehringer Ingelheim Anticoagulants Product
Table 124. Boehringer Ingelheim Recent Development
Table 125. Johnson & Johnson Corporation Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Johnson & Johnson Anticoagulants Product
Table 129. Johnson & Johnson Recent Development
Table 130. Genentech (Roche) Corporation Information
Table 131. Genentech (Roche) Description and Business Overview
Table 132. Genentech (Roche) Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Genentech (Roche) Anticoagulants Product
Table 134. Genentech (Roche) Recent Development
Table 135. AstraZeneca Corporation Information
Table 136. AstraZeneca Description and Business Overview
Table 137. AstraZeneca Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. AstraZeneca Anticoagulants Product
Table 139. AstraZeneca Recent Development
Table 140. Bristol-Myers Squibb Corporation Information
Table 141. Bristol-Myers Squibb Description and Business Overview
Table 142. Bristol-Myers Squibb Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Bristol-Myers Squibb Anticoagulants Product
Table 144. Bristol-Myers Squibb Recent Development
Table 145. Aspen Corporation Information
Table 146. Aspen Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Aspen Description and Business Overview
Table 148. Aspen Anticoagulants Product
Table 149. Aspen Recent Development
Table 150. Lilly Corporation Information
Table 151. Lilly Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Lilly Description and Business Overview
Table 153. Lilly Anticoagulants Product
Table 154. Lilly Recent Development
Table 155. Otsuka Corporation Information
Table 156. Otsuka Description and Business Overview
Table 157. Otsuka Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Otsuka Anticoagulants Product
Table 159. Otsuka Recent Development
Table 160. Pfizer Corporation Information
Table 161. Pfizer Description and Business Overview
Table 162. Pfizer Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Pfizer Anticoagulants Product
Table 164. Pfizer Recent Development
Table 165. Daiichi Sankyo Corporation Information
Table 166. Daiichi Sankyo Description and Business Overview
Table 167. Daiichi Sankyo Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Daiichi Sankyo Anticoagulants Product
Table 169. Daiichi Sankyo Recent Development
Table 170. The Medicines Company Corporation Information
Table 171. The Medicines Company Description and Business Overview
Table 172. The Medicines Company Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. The Medicines Company Anticoagulants Product
Table 174. The Medicines Company Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Anticoagulants Distributors List
Table 178. Anticoagulants Customers List
Table 179. Anticoagulants Market Trends
Table 180. Anticoagulants Market Drivers
Table 181. Anticoagulants Market Challenges
Table 182. Anticoagulants Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Anticoagulants Product Picture
Figure 2. Global Anticoagulants Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anticoagulants Sales Market Share by Application in 2021 & 2027
Figure 6. VTE Examples
Figure 7. ACS/MI Examples
Figure 8. AF Examples
Figure 9. Others Examples
Figure 10. Global Anticoagulants Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Anticoagulants Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Anticoagulants Sales (K MT) Growth Rate (2016-2027)
Figure 13. Global Anticoagulants Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 14. Global Anticoagulants Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Anticoagulants Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Anticoagulants Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Anticoagulants Sales (K MT) Growth Rate (2016-2027)
Figure 18. Europe Anticoagulants Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Anticoagulants Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Anticoagulants Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Anticoagulants Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Anticoagulants Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Anticoagulants Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Anticoagulants Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Anticoagulants Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Anticoagulants Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Anticoagulants Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Anticoagulants Players Market Share by Revenue in Anticoagulants: 2016 & 2020
Figure 29. Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Anticoagulants Revenue Share by Type (2016-2021)
Figure 31. Global Anticoagulants Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Anticoagulants Revenue Share by Application (2016-2021)
Figure 33. Global Anticoagulants Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Anticoagulants Sales Market Share by Type in 2020
Figure 35. North America Anticoagulants Sales Market Share by Application in 2020
Figure 36. Europe Anticoagulants Sales Market Share by Type in 2020
Figure 37. Europe Anticoagulants Sales Market Share by Application in 2020
Figure 38. China Anticoagulants Sales Market Share by Type in 2020
Figure 39. China Anticoagulants Sales Market Share by Application in 2020
Figure 40. Japan Anticoagulants Sales Market Share by Type in 2020
Figure 41. Japan Anticoagulants Sales Market Share by Application in 2020
Figure 42. Southeast Asia Anticoagulants Sales Market Share by Type in 2020
Figure 43. Southeast Asia Anticoagulants Sales Market Share by Application in 2020
Figure 44. India Anticoagulants Sales Market Share by Type in 2020
Figure 45. India Anticoagulants Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Anticoagulants
Figure 48. Manufacturing Process Analysis of Anticoagulants
Figure 49. Anticoagulants Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
注射用抗凝固剤のグローバル市場2021 The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injec…- 新規経口抗凝固剤（NOAC）のグローバル市場調査 2019年 The global Novel Oral AntiCoagulants (NOAC) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Novel Oral AntiCoagulants (NOAC) volume and value at global level, regional level and company level. From …
- 抗凝固薬のグローバル市場調査 2019年 The global Anticoagulants Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anticoagulants Drug volume and value at global level, regional level and company level. From a global perspective, this…
- 世界の血管内皮増殖因子（VEGF）阻害剤市場規模・現状・予測（2021年-2027年） Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels. The vascular endothelial growth factor is a protein that can trigger endothelial cells or pre-existing vessels to form new blood vessels. However, overexpression of …
- 低分子量ヘパリンのグローバル市場2021 Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage. Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular wei…